Toxoplasma Gondii 2020
DOI: 10.1016/b978-0-12-815041-2.00017-7
|View full text |Cite
|
Sign up to set email alerts
|

Effectors produced by rhoptries and dense granules: an intense conversation between parasite and host in many languages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 116 publications
0
3
0
Order By: Relevance
“…However, type II and, to a lesser extent, type III strains have an increased ability to use DCs as Trojan horses for dissemination compared to type I (Lambert et al, 2009 ). The difference in virulence between the major strains of Toxoplasma is due to multiple polymorphic effectors that act in concert to modulate murine immune responses at different steps, a subject that has been reviewed in-depth elsewhere (Melo et al, 2011 ; Boothroyd and Hakimi, 2020 ). The strain variation in specific phenotypes is not only limited to clonal types but is also present within the same haplogroups, possibly due to the presence of polymorphic effectors or differential expression of effector proteins (Khan et al, 2009 ; Melo et al, 2013 ; Yang et al, 2013 ).…”
Section: Toxoplasma Effectorsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, type II and, to a lesser extent, type III strains have an increased ability to use DCs as Trojan horses for dissemination compared to type I (Lambert et al, 2009 ). The difference in virulence between the major strains of Toxoplasma is due to multiple polymorphic effectors that act in concert to modulate murine immune responses at different steps, a subject that has been reviewed in-depth elsewhere (Melo et al, 2011 ; Boothroyd and Hakimi, 2020 ). The strain variation in specific phenotypes is not only limited to clonal types but is also present within the same haplogroups, possibly due to the presence of polymorphic effectors or differential expression of effector proteins (Khan et al, 2009 ; Melo et al, 2013 ; Yang et al, 2013 ).…”
Section: Toxoplasma Effectorsmentioning
confidence: 99%
“…Toxoplasma modulates host pathways through the secretion and delivery of GRA and ROP effectors from its dense granule and rhoptry organelles, respectively, to the host cell cytoplasm. Although some Toxoplasma secreted GRAs and ROPs help to evade host immunity (Hunter and Sibley, 2012 ; Butcher et al, 2014 ; Hakimi and Bougdour, 2015 ; Hakimi et al, 2017 ; Boothroyd and Hakimi, 2020 ), others activate it (Melo et al, 2011 ; Hunter and Sibley, 2012 ; Hakimi et al, 2017 ; Boothroyd and Hakimi, 2020 ). This dynamic balance is required by the parasite to convert to bradyzoites and form tissue cysts, which are orally infectious to other intermediate hosts, thus favoring further transmission.…”
Section: Introductionmentioning
confidence: 99%
“…In fact, concerning host-pathogen relationship and immunological cross-talk, T. gondii modulates host pathways through the secretion and delivery of endogenous effectors in order to try to evade host immunity or, in other cases, to activate it [42]. This balance is required by the parasite for the conversion into bradyzoites that form tissue cysts, orally transmitted to intermediate hosts [31].…”
Section: Resultsmentioning
confidence: 99%